When a question has an answer: Rationale for our early termination of the HEART trial
- 1 June 1995
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (16) , 1173-1175
- https://doi.org/10.1016/s0002-9149(99)80753-x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)The Lancet, 1995
- ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarctionThe Lancet, 1995
- The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial InfarctionNew England Journal of Medicine, 1995
- The TRAndolapril Cardiac Evaluation (TRACE) study: Rationale, design, and baseline characteristics of the screened populationThe American Journal of Cardiology, 1994
- Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.Circulation, 1994
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992
- Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1992
- How Should Results from Completed Studies Influence Ongoing Clinical Trials?Annals of Internal Medicine, 1991